We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current ARTL market cap is 3.72M. The company's latest EPS is USD -2.8779 and P/E is -0.40.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.61M | -3.24M | -2.59M | -2.51M | -1.2M |
| Net Income | -2.45M | -3.07M | -2.48M | -2.43M | -1.13M |
| Year End 31 December 2023 | 2020 | 2021 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -4.69M | -7.44M | -4.04M | -10.29M | -9.93M |
| Net Income | -4.66M | -7.44M | -4.04M | -10.08M | -9.29M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 15.5M | 13.04M | 10.35M | 8.33M | 7.14M |
| Total Liabilities | 921k | 1.29M | 817k | 1.03M | 775k |
| Total Equity | 14.58M | 11.75M | 9.54M | 7.3M | 6.36M |
| Year End 31 December 2023 | 2020 | 2021 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 4.38M | 12.64M | 28.25M | 20.42M | 13.04M |
| Total Liabilities | 502k | 593k | 1.08M | 1.02M | 1.29M |
| Total Equity | 3.88M | 12.04M | 27.17M | 19.4M | 11.75M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -5.61M | -8.21M | -2.94M | -5.01M | -5.78M |
| Investing | 766k | 3.51M | 1.27M | 3.02M | 7.27M |
| Financing | 535k | 567k | 55k | 55k | 55k |
| Year End 31 December 2023 | 2020 | 2021 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -4.35M | -6.14M | -2.67M | -8.01M | -8.21M |
| Investing | N/A | -3.44M | -10.03M | 2.96M | 3.51M |
| Financing | 1.98M | 14.11M | 18.26M | N/A | 567k |
| Market Cap | 3.72M |
| Price to Earnings Ratio | -0.40 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.32 |
| Price to Book Ratio | 0.32 |
| Dividend Yield | - |
| Shares Outstanding | 3.23M |
| Average Volume (1 week) | 30.16k |
| Average Volume (1 Month) | 27.85k |
| 52 Week Change | -22.62% |
| 52 Week High | 1.75 |
| 52 Week Low | 0.91 |
| Spread (Intraday) | 0.16 (12.8%) |
| Company Name | Artelo Biosciences Inc |
| Address |
564 wedge lane fernley, nevada 89408 |
| Website | https://www.artelobio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
